. TREM2 Acts Downstream of CD33 in Modulating Microglial Pathology in Alzheimer’s Disease. Neuron doi.org/10.1016/j.neuron.2019.06.010

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.

This paper appears in the following:

News

  1. Deleting CD33 Benefits Mice—If Their Microglia Express TREM2